Substitution of Chronic Insulin Therapy with Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Co-transporter-2 Inhibitors

Journal Title: Diabetes Research – Open Journal - Year 2015, Vol 1, Issue 3

Abstract

Insulin is a very useful and widely used treatment for diabetes. Temporary insulin therapy improves glucose toxicity due to improved β-cell function of the pancreas. Upon achieving glycemic control, insulin treatment could be discontinued and substituted with oral hypoglycemic agents. Nevertheless, insulin therapy is associated with side effects such as hypoglycemia, allergic reactions, and angioneurotic edema. Over this past decade, there have been rapid advances in diabetes treatment, including the introduction of Dipeptidyl peptidase-4 (DPP-4) inhibitors and Sodium-glucose cotransporter-2 (SGLT2) inhibitors. We present here the case of a patient with type 2 diabetes who discontinued insulin therapy after more than 20 years by switching to oral hypoglycemic agents including a DPP-4 inhibitor and a SGLT2 inhibitor.

Authors and Affiliations

Hideshi Okada

Keywords

Related Articles

NLRP3 Inflammasome Signaling Platform as New Pharmacological Target for Metaflammation

Metaflammation is a metabolic inflammatory state characterized by chronic, lowgrade inflammatory response initiated by excess nutrients in metabolic cells.1 The inflammatory signaling conducted by the metabolic cell eve...

Effect of Low Carbohydrate Diet on Type 2 Diabetic Patients and Usefulness of M-Value

Background: Debate between the Calorie Restriction (CR) and Low-Carbohydrate Diet (LCD) has been continued for several years. We have started LCD therapy for diabetic patients since 1999, and experienced good response to...

Wellness Fasting and Hyperketosis

Ketoacidosis is sometimes a lethal complication of diabetes mellitus.1-3 Ketone bodies are considered to be the toxic elements of ketoacidosis. Wilder3 considered that the threshold of ketogenesis (i.e. the maximal rati...

Sleep and Diabetes in Adolescents: A Battle between Physiology and Social Factors

About 200,000 of individuals under 20 years of age have been diagnosed with diabetes. Many of them have type 1 diabetes (T1D) but type 2 diabetes (T2D), a disease that used to be seen primarily in adults over age 45, is...

Type 1 Diabetes Update at Children With Diabetes Community

Of the estimated 415 million people living with diabetes worldwide, 10% have Type 1 Diabetes (T1D) meaning they will remain insulin dependent until a cure is found. Globally, we can observe an increasing trend of about 5...

Download PDF file
  • EP ID EP550012
  • DOI 10.17140/DROJ-1-113
  • Views 134
  • Downloads 0

How To Cite

Hideshi Okada (2015). Substitution of Chronic Insulin Therapy with Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Co-transporter-2 Inhibitors. Diabetes Research – Open Journal, 1(3), 77-78. https://europub.co.uk/articles/-A-550012